However, in contrast to the results of the studies on RCC, certain studies have indicated that high CAIX expression predicts poor prognosis in patients with other cancers, such as ovarian, gastric, lung, etc. [71], [72], [73]. This evidence concerns the gene CA9 and renal cell carcinoma.